Trimethylammonium

Trimethylammonium

SCHEMBL6398997

CCCS(=O)(=O)O.CN(C)C

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.41
PDE4A P27815 1/20 0.41
LMNA P02545 1/20 0.41
SLC6A6 P31641 1/20 0.41
CYP2C19 P33261 1/20 0.41
BLM P54132 1/20 0.41
APP P05067 1/20 0.38
CA1 P00915 2/20 0.33
EPHX2 P34913 1/20 0.32
MEN1 O00255 1/20 0.32
TSHR P16473 1/20 0.32
KMT2A Q03164 1/20 0.32
CA12 O43570 1/20 0.31
CA2 P00918 1/20 0.31
CA14 Q9ULX7 1/20 0.31
TP53 P04637 1/20 0.30
S1PR2 O95136 1/20 0.30
S1PR1 P21453 1/20 0.30
S1PR3 Q99500 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL21631138 0.97 PTGS1 (0.39) PTGS1PDE4ALMNASLC6A6CYP2C19
Sulfuric Acid SCHEMBL28349750 0.97 PTGS1 (0.39) PTGS1PDE4ALMNASLC6A6CYP2C19
SCHEMBL6916909 0.94
SCHEMBL27854285 0.92 PTGS1 (0.39) PTGS1PDE4ALMNASLC6A6CYP2C19
SCHEMBL28849565 0.91 LMNA (0.47) PTGS1PDE4ALMNASLC6A6CYP2C19
SCHEMBL5268 0.91
N,N-Dimethylethanaminium SCHEMBL2760541 0.89 PTGS1 (0.43) PTGS1PDE4ALMNASLC6A6CYP2C19
Ethane SCHEMBL25228294 0.88
SCHEMBL20533802 0.88
SCHEMBL20533675 0.88

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260015560-A1 COMPOSITIONS FOR POST-CMP CLEANING OF MICROELECTRONIC DEVICES ENTEGRIS INC (US) 2026-01-15 US claimed
US-20050002795-A1 Method for improving the performance of electrokinetic micropumps KIRBY BRIAN J (US) 2005-01-06 US claimed
US-20040173459-A1 Method for improving the performance of electrokinetic micropumps KIRBY BRIAN J (US) 2004-09-09 US claimed
US-20040057835-A1 Method for improving the performance of electrokinetic micropumps SANDIA NATIONAL LABORATORIES 2004-03-25 US claimed
US-20260015560-A1 COMPOSITIONS FOR POST-CMP CLEANING OF MICROELECTRONIC DEVICES ENTEGRIS INC (US) 2026-01-15 US disclosed
EP-4466740-A1 ORGANIC SULFONATE ELECTROLYTE ADDITIVES FOR ZINC BATTERIES Octet Scientific, Inc. (US) 2024-11-27 EP disclosed
US-20230246229-A1 ORGANIC SULFONATE ELECTROLYTE ADDITIVES FOR ZINC BATTERIES Octet Scientific, Inc. 2023-08-03 US disclosed
WO-2023141301-A1 ORGANIC SULFONATE ELECTROLYTE ADDITIVES FOR ZINC BATTERIES Octet Scientific, Inc. (US) 2023-07-27 WO disclosed
CN-108950091-B Eutectic solvent, preparation method thereof and application of eutectic solvent in preparation of glucose by hydrolyzing cellulose 河北科技大学 2021-12-03 CN disclosed
CN-108017610-B Preparation method of vitamin E 浙江新和成药业有限公司 2020-11-06 CN disclosed
CN-108017610-A A kind of preparation method of vitamin E 浙江新和成药业有限公司 2018-05-11 CN disclosed
US-9918988-B2 Ammonium derivatives for the treatment of hepatitis C BRISTOL-MYERS SQUIBB COMPANY (US) 2018-03-20 US disclosed
US-20040057835-A1 Method for improving the performance of electrokinetic micropumps SANDIA NATIONAL LABORATORIES 2004-03-25 US disclosed
US-20040057835-A1 Method for improving the performance of electrokinetic micropumps SANDIA NATIONAL LABORATORIES 2004-03-25 US disclosed
EP-1137624-A1 METHOD OF PREPARATION OF 4-AMINODIPHENYLAMINE DUSLO, a.s. (SK) 2001-10-04 EP disclosed
WO-2000035853-A1 METHOD OF PREPARATION OF 4-AMINODIPHENYLAMINE DUSLO, A.S. SAL'A (SK) 2000-06-22 WO disclosed
US-5567349-A Photo cross-linkable liquid crystals HOFFMANN-LA ROCHE INC. (US) 1996-10-22 US disclosed
EP-0494686-B1 Process for effecting high efficiency separations by capillary electrophoresis MILLIPORE CORP (US) 1995-03-08 EP disclosed
US-5192405-A Process for effecting high efficiency separations by capillary electrophoresis MILLIPORE CORPORATION (US) 1993-03-09 US disclosed
EP-0494686-A1 Process for effecting high efficiency separations by capillary electrophoresis MILLIPORE CORPORATION (US) 1992-07-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260015560-A1 COMPOSITIONS FOR POST-CMP CLEANING OF MICROELECTRONIC DEVICES TET2, ASIC1, PIEZO1 PTGS1 3048/4885PDE4A 3059/4885LMNA 2078/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.